Cells acquiring this persistent quiescent-like (PQL) phenotype display higher in vivo metastatic capacity and express a YAP1-dependent fetal signature that is also detected in a subset of untreated CRC tumors. This evidence concerns the gene YAP1 and colorectal carcinoma.